Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ocugen, Inc. - Common Stock
(NQ:
OCGN
)
0.9935
-0.0665 (-6.27%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocugen, Inc. - Common Stock
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
36
37
Next >
3 of the Fastest-Growing Stocks on the Planet in 2023
↗
January 26, 2023
These hypergrowth stocks are expected to deliver up to 1,075% sales growth this year.
Via
The Motley Fool
3 Under-the-Radar Stocks With 590% to 772% Upside in 2023, According to Wall Street
↗
January 23, 2023
Select analysts expect these small-caps stocks to catapult higher in the new year.
Via
The Motley Fool
7 ‘Loser’ Stocks to Short for Big Profits
↗
January 11, 2023
These stocks to short can generate significant profits for investors, as they are all tremendously overvalued at this point.
Via
InvestorPlace
Exclusive: Top 10 Most Searched Tickers On Benzinga Pro In 2022 — Where Do SPY, Tesla, Apple And AMC Rank?
↗
January 09, 2023
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a leading source for traders to see the latest news on the overall market and individual tickers all in one...
Via
Benzinga
Ocugen Announces Encouraging Data From Late-Stage COVID-19 Vaccine Study
↗
January 09, 2023
Via
Benzinga
Why Shares of Ocugen Jumped Thursday
↗
December 29, 2022
Could short-sellers be enacting a squeeze?
Via
The Motley Fool
Why Is Party City (PRTY) Stock Up 41% Today?
↗
January 09, 2023
Party City (PRTY) stock is in the news Monday as investors prepare for the celebration goods company to file for bankruptcy.
Via
InvestorPlace
Why Is Ocugen (OCGN) Stock Up Today?
↗
January 09, 2023
Ocugen is hoping its Indian-made inactivated Covid-19 shot can provide a low-cost boost for those previously given MRNA-based vaccines.
Via
InvestorPlace
Tesla's Delivery Wait Times Go Up, China Wants To Secure License For Generic Version Of Pfizer's Paxlovid, India-Made iPhone Exports Surpass $2.5B: Today's Top Stories
↗
January 09, 2023
Bloomberg
Via
Benzinga
Ocugen Announces Positive Top-Line Data for COVID-19 Vaccine Candidate COVAXIN™ (BBV152) in Phase 2/3 Immuno-bridging and Broadening Study: Both Co-primary Endpoints Met
January 09, 2023
From
Ocugen
Via
GlobeNewswire
Why Ocugen Stock Wilted on Wednesday
↗
November 09, 2022
A prognosticator got less bullish on the company's prospects, and investors took this to heart.
Via
The Motley Fool
7 Hot Meme Stocks of 2022 to Sell Before 2023
↗
December 25, 2022
The value of most of the meme stocks have plunged, but there are still many meme stocks to sell at this point.
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Tuesday
↗
December 20, 2022
On Tuesday, 298 companies achieved new lows for the year.
Via
Benzinga
Ocugen, Inc. (OCGN) Q3 2022 Earnings Call Transcript
↗
November 08, 2022
OCGN earnings call for the period ending September 30, 2022.
Via
The Motley Fool
Why Is Agrify (AGFY) Stock Down 50% Today?
↗
December 16, 2022
Agrify (AGFY) stock is on the move Friday as the company's shares take a beating after revealing details of a stock offering.
Via
InvestorPlace
OCGN Stock Alert: What to Know About Ocugen’s Latest Phase 3 Clinical Trial
↗
December 16, 2022
OCGN stock fell into the red despite Ocugen's success in advancing a regenerative cell therapy product evaluation.
Via
InvestorPlace
Ocugen Announces Phase 3 Confirmatory Clinical Trial Agreement for NeoCart®
December 16, 2022
Important next step for Ocugen’s regenerative cell therapy in orthopedics since announcing pipeline expansion in May 2022
From
Ocugen
Via
GlobeNewswire
Ocugen, Inc. to Ring the Nasdaq Stock Market Closing Bell
December 13, 2022
From
Ocugen
Via
GlobeNewswire
7 Tech Stocks to Sell Before They Topple in 2023
↗
December 08, 2022
It's much harder now than in 2021 to find tech stocks to sell, but some tech names are still dramatically overvalued.
Via
InvestorPlace
Ocugen Announces Update on OCU400 Phase 1/2 Clinical Trial Targeting Retinitis Pigmentosa and Leber Congenital Amaurosis
December 07, 2022
From
Ocugen
Via
GlobeNewswire
Ocugen to Present at 3rd Annual Dry AMD Therapeutics Summit
November 28, 2022
From
Ocugen
Via
GlobeNewswire
3 Stocks to Avoid Right Now
↗
November 17, 2022
Even though many stocks have fallen sharply in price, not all are bargains -- investors must remains selective.
Via
The Motley Fool
Why Ocugen Stock Popped by 7% on Tuesday
↗
November 08, 2022
A third-quarter report, complete with clinical updates, is more than enough to satisfy the biotech's bulls.
Via
The Motley Fool
SolarEdge Technologies, LivePerson, TaskUs And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
↗
November 08, 2022
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Ocugen Provides Business Update & Third Quarter 2022 Financial Results
November 08, 2022
From
Ocugen
Via
GlobeNewswire
Why TripAdvisor Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket
↗
November 08, 2022
Gainers
Via
Benzinga
3 High-Octane Growth Stocks With 357% to 571% Upside, According to Wall Street
↗
November 02, 2022
Select analysts and pundits foresee game-changing upside from this fast-paced trio.
Via
The Motley Fool
Warning! Don’t Even Consider Buying These 7 Dead-Money Stocks
↗
November 01, 2022
These dead-money stocks exhibit incredible volatility and present themselves as remarkably risky bets in this current economic environment.
Via
InvestorPlace
Ocugen to Host Conference Call on Tuesday, November 8 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2022 Financial Results
October 27, 2022
From
Ocugen
Via
GlobeNewswire
Ocugen to Host R&D Day in New York City on Tuesday, November 1, 2022
October 19, 2022
From
Ocugen
Via
GlobeNewswire
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
36
37
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
